GSK’s consumer health spinoff Haleon is expected to list on the London stock exchange next month. But don’t expect Pfizer to stick along for the ride. Pfizer announced on Wednesday that it plans on ...

Read More »

Pfizer Changes Its Mind, Will Sell Down Stake in GSK's Haleon Unit

Pfizer (NYSE:PFE) will sell down its stake in Haleon, the consumer healthcare unit of GSK (LON:GSK), after its listing in London planned for later this month, GSK said on Wednesday. That indicates a ...

Read More »

GSK Confirms Consumer Healthcare Unit Spin-off: What Investors Should Know

Close on the heels of an M&A deal, GlaxoSmithKline plc (NYSE: GSK) confirmed the spin-off of the consumer healthcare business it jointly owns with U.S. pharma giant Pfizer , Inc. (NYSE: NYSE:PFE).

Read More »

GlaxoSmithKline (LON:GSK) Receives Hold Rating from Deutsche Bank Aktiengesellschaft

GlaxoSmithKline (LON:GSK – Get Rating)‘s stock had its “hold” rating reiterated by Deutsche Bank Aktiengesellschaft in a research note issued to investors on Tuesday, Digital Look reports. They ...

Read More »

Unilever Surges After Appointing Activist Nelson Peltz to its Board

Pressure on the board increased earlier this year after it bid what was seen to be an unrealistically high sum of 50 billion pounds ($63 billion) for the healthcare arm of GlaxoSmithKline (LON:GSK).

Read More »